IP Verse

ACTAVIS LABORATORIES FL, INC. et al. vs Janssen Oncology, Inc. et al.

The detailed information for PTAB case with proceeding number IPR2017-00853 filed by ACTAVIS LABORATORIES FL, INC. et al. against Janssen Oncology, Inc. et al. on Feb 8, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-00853
Filing Date: Feb 8, 2017
Petitioner: ACTAVIS LABORATORIES FL, INC. et al.
Respondent: Janssen Oncology, Inc. et al.
Status: Final Written Decision
Respondent Application Number: 13034340
Respondent Tech Center: 1600
Respondent Patent Number: 8822438
Institution Decision Date: Apr 12, 2017
Termination Date: Jan 17, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Final Written Decision	Jan 17, 2018	PAPER	BOARD
ERRATUM	Apr 13, 2017	PAPER	BOARD
DECISION - Institution of Inter Partes Review and Grant of Motion for Joinder	Apr 12, 2017	PAPER	BOARD
Janssen Oncology Inc.s Waiver of Preliminary Response Pursuant to 37 C.F.R. 42.107(b)	Mar 23, 2017	PAPER	PATENT OWNER
REPLY IN SUPPORT OF PETITIONERS MOTION FOR JOINDER WITH RELATED INSTITUTED INTER PARTES REVIEW OF U.S. PATENT NO. 8,822,438	Mar 17, 2017	PAPER	PETITIONER
CORRECTED Ex. 1029-U.S. Patent 5,688,977	Mar 9, 2017	EXHIBIT	PETITIONER
EXPUNGED	Mar 8, 2017	PAPER	BOARD
Notice of Accord Filing Date	Mar 8, 2017	PAPER	BOARD
JSN 2002 2015-08-11 DI 8 Actavis Lab FL Inc. Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2006 2015-08-17 DI 22 Hikma Pharmaceuticals, LLC Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2007 2015-08-17 DI 25 Amneal Pharms of New York LLC Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2011 2015-09-08 DI 42 Teva Pharmaceuticals USA, Inc. Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
Janssen Oncology, Inc.s Opposition to Motion for Joinder	Mar 8, 2017	PAPER	PATENT OWNER
JSN 2003 2015-08-17 DI 19 Dr. Reddy's Lab Inc. Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2004 2015-08-17 DI 20 Dr. Reddy's Lab Ltd. Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2005 2015-08-17 DI 21 West-Ward Pharmaceutical Corp Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2008 2015-08-17 DI 26 Amneal Pharmaceuticals LLC Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2009 2015-09-01 DI 35 Sun Pharmaceuticals Industries, Inc. Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2010 2015-09-01 DI 36 Sun Pharmaceuticals Industries, LTD Waiver of Service	Mar 8, 2017	EXHIBIT	PATENT OWNER
JSN 2012 2017-02-08 Email from J. Wong to Patent Owner's Counsel	Mar 8, 2017	EXHIBIT	PATENT OWNER
Janssen Oncology, Inc.s Exhibit List	Mar 8, 2017	PAPER	PATENT OWNER
Janssen Oncology, Inc.s Mandatory Notices	Feb 21, 2017	PAPER	PATENT OWNER
Janssen Oncology, Inc.s Power of Attorney	Feb 21, 2017	PAPER	PATENT OWNER
Janssen Oncology, Inc.s Exhibit List	Feb 21, 2017	PAPER	PATENT OWNER
JSN 2001 Notice of Termination of Preprocessing of Ex Parte Reexamination Request	Feb 21, 2017	EXHIBIT	PATENT OWNER
Actavis Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Amneal Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Dr. Reddy's Lab Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Teva Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Hikma Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Petition for Inter Partes Review	Feb 8, 2017	PAPER	PETITIONER
Motion For Joinder With Related Instituted Inter Partes Review Of U.S. Patent No. 8,822,438	Feb 8, 2017	PAPER	PETITIONER
Ex. 1001-U.S. Patent No. 8,822,438	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1002-Declaration of Dr. Marc B Garnick	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1004-Gerber(1990	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1006-Tannock (1996)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1008- July 3, 2012 Response '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1009-Ryan (2013)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1013 -Jul, 3 2013 NOA '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1014-Oct. 25, 2013 NOA '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Sun Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
West-Ward Power of Attorney	Feb 8, 2017	PAPER	PETITIONER
Ex. 1003-O'Donnell (2004)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1005-U.S. Patent No. 5,604,213.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1007-Feb 3, 2012 Office Action '438 patent.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1010-Jan 11, 2013 Response '438 patent.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1011-Mar 4, 2013 Office Action '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1012-June 4, 2013 Response '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1015 -Feb. 11,2014 NOA '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1016 -Jun 2, 2014 NOA '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1017-Declaration of Ivan T Hofmann	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1018-2011 Zytiga Approval PI	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1019-2015 Zytiga-PI Brochure.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1020-Harris (2002)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1022-Tannock (2004)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1021-Oh- Secondary Hormonal (2002)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1023-Attard (2005)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1024-Hellerstedt (2002)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1025-Kasper-Harrisons Principles (2005)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1028-Jubelirer (1989)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1030-US FDA Release May 29, 200	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1031-Tannock (1989)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1039-Sept 11, 2012 Office Action '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1041-Cancer.org (ACS Website) 06-28-2016	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1046-Drugs@fda	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1048-Galderma Labs v. Tolmar (Fed. Cir. 2013)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1051-Mayo Clinic Website (06-28-2016)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1026-Auchus (2001)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1027-Costa-Santos (2004)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1029-U.S. Patent 5,688,977.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1033-Scher (2012)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1034-deBono (2011).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1035-Orange Book Listing-Zytiga	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1036-Initial Application-'438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1040-Cancer.net (ASCO Patent Website) 06-28-2016	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1045-FDA New Release-Zytiga 2012	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1047-FDA Website-OB-Zytiga (06-30-2016)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1049- Jevtana Website (06-28-2016)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1050-Kirby (2011).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1053- Merck v. Teva (2005)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1054-Murphy- Patent Valuation (2012).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1055-PMLiVe Website (06-30-2016).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1064-Zytiga Brochure (03-2015)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1066-Zytiga Website (06-28-2016)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1070-Sep. 11, 2012 Office Action '438 patent.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1074-May 9, 2014-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1075-May 9, 2014-IDS '438 patent.	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1078-Barrie (1994).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1079-Fakih (002).	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1080-Lam (2006)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1057-Syntex v. Apotx (2005)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1065-Zytiga Labe (05020-2015)	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1068-Nov. 25, 2011 Office Action '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1069-Dec. 21, 2011 Response '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1071- Oct 3,, 2013-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1072- Oct 3,, 2013-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1073-Jan 10, 2014-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1076-May 30, 2014-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER
Ex. 1077-May 30, 2014-IDS '438 patent	Feb 8, 2017	EXHIBIT	PETITIONER